Lifecore BiomedicalLFCR
那斯達克 · USD
4.64
+0.09
(+1.98%)
收盤 08/26 03:56 (UTC+8)
08/26 03:56 (UTC+8)
Lifecore BiomedicalLFCR
4.64
+0.09
(+1.98%)
財務數據
損益表
- 0.30
- 0.36
- 0.38
- 0.25
- 0.33
- 0.35
- 0.36
- 0.31
- 0.23
- 0.34
- 22.95
- 18.42
- 6.11
- -34.79
- 31.81
- 7.95
- 3.67
- -
- -
- 47.32
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q3 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 34,167 | 23,193 | 31,109 | 36,444 | 35,154 | 32,564 | 24,705 | 37,886 | 35,703 | 30,150 |
營業成本 | 22,092 | 18,731 | 23,318 | 22,462 | 25,309 | 21,480 | 19,318 | 20,614 | 23,810 | 20,193 |
營業毛利 | 12,075 | 4,462 | 7,791 | 13,982 | 9,845 | 11,084 | 5,387 | 17,272 | 11,893 | 9,957 |
營業費用 | 9,508 | 9,134 | 10,858 | 8,564 | - | 13,043 | - | 15,125 | 12,787 | 11,440 |
研發費用 | 1,537 | 1,217 | 1,963 | 2,103 | 2,045 | 1,924 | 2,186 | 2,161 | 2,170 | 2,098 |
推銷及管理費用 | 7,971 | 7,917 | 8,895 | 8,980 | 9,162 | 11,119 | 14,785 | 12,226 | 9,699 | 9,342 |
非經常性項目費用 | - | - | - | -2,519 | 772 | - | - | 738 | 918 | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 2,567 | -4,672 | -3,067 | 5,327 | -9,029 | -1,959 | -11,584 | 2,149 | -896 | -1,483 |
其他收入及費用 | - | - | -207 | -1,011 | -7,162 | 881 | 697 | -3,500 | 20,186 | 19,732 |
利息費用 | 7,751 | 7,348 | 6,384 | 5,521 | 5,481 | 5,450 | 5,368 | 5,790 | 4,290 | 4,072 |
稅前純益 | -6,133 | -14,937 | -9,658 | -1,114 | -14,777 | -6,528 | -16,255 | -7,143 | 15,002 | 14,177 |
所得稅 | 23 | 43 | 333 | 33 | -8 | 43 | -25 | -57 | 217 | -65 |
稅後純益 | -6,156 | -14,980 | -9,991 | -1,147 | -14,769 | -6,571 | -16,230 | -7,083 | 15,632 | 14,218 |
基本每股稅後盈餘(元) | -0.19 | -0.43 | -0.29 | -0.06 | -0.47 | -0.25 | -0.53 | -0.23 | 0.51 | 0.47 |
稀釋每股稅後盈餘(元) | -0.19 | -0.43 | -0.29 | -0.03 | -0.48 | -0.23 | -0.53 | -0.19 | 0.42 | 0.45 |
基本平均股數(千股) | 37574.00 | 37477.00 | 37402.00 | 37007.00 | 37020.00 | 34360.00 | 30855.00 | 30548.00 | 30487.00 | 30458.00 |
稀釋平均股數(千股) | 37574.00 | 37477.00 | 37402.00 | 37007.00 | 37020.00 | 34360.00 | 30855.00 | 43202.00 | 36608.00 | 36419.00 |
還原基本每股稅後盈餘(元) | -0.19 | -0.43 | -0.29 | -0.06 | -0.47 | -0.25 | -0.53 | -0.23 | 0.51 | 0.47 |
還原稀釋每股稅後盈餘(元) | -0.19 | -0.43 | -0.29 | -0.03 | -0.48 | -0.23 | -0.53 | -0.19 | 0.42 | 0.45 |
還原基本平均股數(千股) | 37,574 | 37,477 | 37,402 | 37,007 | 37,020 | 34,360 | 30,855 | 30,548 | 30,487 | 30,458 |
還原稀釋平均股數(千股) | 37,574 | 37,477 | 37,402 | 37,007 | 37,020 | 34,360 | 30,855 | 43,202 | 36,608 | 36,419 |
EBITDA(千元) | 4,133 | -5,279 | -1,293 | 6,321 | -7,220 | 966 | -8,894 | 1,569 | 22,145 | 19,991 |